Skip to content

Long-term Canadian study shows HIV-exposed children have worse health outcomes

wavebreakmedia/Shutterstock.com

Rate of neural tube defects is no higher on dolutegravir

Andrey_Popov/Shutterstock.com

New data suggest PrEP in pregnancy is safe

Laurén Gómez at AIDS 2022. Photo by Rosalie Hayes.

Botswana is ‘going for gold’ in eliminating vertical HIV transmission. Can the rest of Africa catch up?

mothers2mothers/USAID Southern Africa. Creative Commons licence.

Pregnant and breastfeeding cis women are paying the price for exclusion from PrEP research

Syda Productions/Shutterstock.com

Top 5 HIV treatment stories from CROI 2022

Professor Samir Gupta (top right) presenting a study on lenacapavir at CROI 2022.

Top 5 stories on HIV prevention from CROI 2022

Professor Raphael Landovitz (bottom left) presenting the latest data on injected PrEP at CROI 2022.

Top 5 stories on HIV treatment and care in Africa from CROI 2022

Maya Jackson-Gibson presenting the study on COVID-19 and adverse birth outcomes at CROI 2022.

Infant weight and height lower with efavirenz than with dolutegravir in pregnancy

Dr Lynda Stranix-Chibanda (bottom right) at CROI 2022.